SCHEMBL2846845

SCHEMBL2846845

COC(C)(C)C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL476497 0.75
SCHEMBL28419828 0.73 ALDH1A1 (0.38)
SCHEMBL22863851 0.73 ALDH1A1 (0.33)
SCHEMBL1685072 0.73 ALDH1A1 (0.33)
SCHEMBL1685071 0.73 ALDH1A1 (0.33)
SCHEMBL22972244 0.73
SCHEMBL11453119 0.73 DGAT1 (0.34)
SCHEMBL11129569 0.71
SCHEMBL1449319 0.71
SCHEMBL626444 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250145629-A1 ION CHANNEL MODULATORS PRAXIS PRECISION MEDICINES, INC. 2025-05-08 US disclosed
US-12145939-B2 Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators PRAXIS PRECISION MEDICINES, INC. (US) 2024-11-19 US disclosed
US-20240043433-A1 ION CHANNEL MODULATORS PRAXIS PRECISION MEDICINES, INC. 2024-02-08 US disclosed
EP-3601284-B1 NAPHTHYRIDINES AS INHIBITORS OF HPK1 HOFFMANN LA ROCHE (CH) 2023-12-27 EP disclosed
US-11767325-B2 Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators PRAXIS PRECISION MEDICINES, INC. (US) 2023-09-26 US disclosed
US-11767325-B2 Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators PRAXIS PRECISION MEDICINES, INC. (US) 2023-09-26 US disclosed
CN-110678466-B Diazanaphthalenes as HPK1 inhibitors 豪夫迈·罗氏有限公司 2023-01-31 CN disclosed
WO-2022072634-A1 BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER SCORPION THERAPEUTICS, INC. (US) 2022-04-07 WO disclosed
US-11034692-B1 Naphthyridines as inhibitors of HPK1 GENENTECH, INC. (US) 2021-06-15 US disclosed
US-11034692-B1 Naphthyridines as inhibitors of HPK1 GENENTECH, INC. (US) 2021-06-15 US disclosed
US-5731318-A NEUROLOGICAL DISORDERS BOEHRINGER INGELHEIM KG (DE) 1998-03-24 US disclosed
US-5607941-A BENZOMORPHAN DERIVATIVES BOEHRINGER INGELHEIM KG (DE) 1997-03-04 US disclosed
US-4969950-A Triazole compounds and methods for regulating plant growth BASF AKTIENGESELLSCHAFT (DE) 1990-11-13 US disclosed
EP-0291852-A1 Triazole compounds, process for their preparation and method for plant growth regulation BASF Aktiengesellschaft (DE) 1988-11-23 EP disclosed
EP-0006449-B1 2-(2-ALKOXYETHYL)-2'-HYDROXY-6.7-BENZOMORPHANE DERIVATIVES, THEIR ACID ADDITION SALTS, MEDICAMENTS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION C.H. BOEHRINGER SOHN (DE) 1982-12-08 EP disclosed
US-4293556-A Analgesic 2-(2-alkoxy-ethyl)-2'-hydroxy-6,7-benzomorphans and salts thereof BOEHRINGER INGELHEIM GMBH (DE) 1981-10-06 US disclosed
EP-0006449-A1 2-(2-Alkoxyethyl)-2'-hydroxy-6.7-benzomorphane derivatives, their acid addition salts, medicaments containing them and process for their preparation C.H. BOEHRINGER SOHN (DE) 1980-01-09 EP disclosed
US-4129704-A Polymerization of vinyl monomers employing a diperoxyester mixture composition prepared by reacting dihydroperoxide and peroxyester forming carbonyl compounds PENNWALT CORPORATION (US) 1978-12-12 US disclosed
US-4097408-A FROM DIHYDOPEROXIDE AND CARBONYL COMPOUND, POLYMERIZATION CATALYSTS PENNWALT CORPORATION (US) 1978-06-27 US disclosed
US-4015012-A ANTHELMINTICS BAYER AKTIENGESELLSCHAFT (DT) 1977-03-29 US disclosed